Toll Free: 1-888-928-9744

Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease, By Dosage Form, By Route Of Administration, By Product Type, By Region, And Segment Forecasts, 2020 - 2027

Published: Mar, 2020 | Pages: 250 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global ophthalmic drugs market size is expected to reach USD 45.8 billion by 2027, registering a CAGR of 5.0%, according to a new report published by Grand View Research, Inc. Advancements in drug delivery systems are anticipated to drive the overall growth.

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

• In 2019, topical route was the largest segment as it is non-invasive route of administration with high patient compliance

• The local ocular route is estimated to be the fastest growing segment over the forecast period

• Prescription drugs held the largest share in 2019 since it is considered to be more effective treatment

• North America led the market for ophthalmic drugs in 2019 due to high disease burden

• Asia Pacific is estimated to be the fastest growing market during the forecast period owing to rising disposable income along with growing awareness regarding various ophthalmic diseases

• Some of the key companies operating in the market are Novartis AG; Allergan PLC; Bausch & Lomb, Inc.; Pfizer, Inc.; Santen Pharmaceutical Co., Ltd.; Regeneron, Bayer AG; and Genentech, Inc.
 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market segmentation & scope
                  1.2. Market definition
                  1.3. Information procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources & third party perspectives
                       1.3.4. Primary research
                  1.4. Information analysis
                       1.4.1. Data analysis models
                  1.5. Market formulation & data visualization
                  1.6. Data validation & publishing
Chapter 2. Executive Summary
                  2.1. Market Outlook
                  2.2. Segment Outlook
                  2.3. Competitive Insights
Chapter 3. Global Ophthalmic Drugs Market Variables, Trends & Scope
                  3.1. Ophthalmic Drugs Market Lineage outlook
                       3.1.1. Parent market outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Pipeline Analysis
                  3.4. Cost Structure Analysis
                  3.5. Patent Expiry Scenario
                  3.6. Epidemiology
                  3.7. Regulatory Framework
                  3.8. User Perspective Analysis
                  3.9. Unmet Need Analysis
                  3.10. Primary Research Analysis
                       3.10.1. Factors estimated to impact on market growth
                       3.10.2. Market scenario
                       3.10.3. Key KOL responses
                  3.11. Market Dynamics
                       3.11.1. Market Driver Analysis
                           3.11.1.1. Increasing incidence and prevalence of eye related disorders
                           3.11.1.2. Increasing R & D pertaining to the development of novel drugs
                           3.11.1.3. Presence of strong emerging pipeline drugs
                           3.11.1.4. Increased funding from both public and private research organizations
                       3.11.2. Market Restraint Analysis
                           3.11.2.1. Loss of patent protection for blockbuster drugs
                  3.12. Ophthalmic Drugs Market Analysis Tools
                       3.12.1. Industry Analysis - Porter’s
                           3.12.1.1. Supplier Power: Low due to large number of manufacturers
                           3.12.1.2. Buyer Power: high due to increasing prevalence of eye related diseases
                           3.12.1.3. Substitution Threat: High due to presence external substitutes
                           3.12.1.4. Threat from new entrant: Moderate due to brand recognition of the existing players
                           3.12.1.5. Competitive rivalry: High due to rigorous competition among key players
                  3.13. PESTEL Analysis
                       3.13.1. Political Landscape
                       3.13.2. Environmental Landscape
                       3.13.3. Social Landscape
                       3.13.4. Technology Landscape
                       3.13.5. Legal Landscape
                  3.14. Major Deals & Strategic Alliances Analysis
                       3.14.1. Joint Ventures
                       3.14.2. Mergers & Acquisitions
                       3.14.3. Licensing & Partnership
                       3.14.4. Technology Collaborations
                       3.14.5. Strategic Divestments
Chapter 4. Ophthalmic Drugs Market - Competitive Analysis
                  4.1. Recent developments & impact analysis, by key market participants
                  4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                  4.3. Public Companies
                       4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                       4.3.2. Company Market Share/Ranking, by region
                       4.3.3. Competitive Dashboard Analysis
                       4.3.4. Market Differentiators
                       4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
                  4.4. Private Companies
                       4.4.1. List of key emerging companies
                       4.4.2. Regional network map
                       4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Ophthalmic Drugs Market: Drug Class Estimates & Trend Analysis
                  5.1. Definitions & Scope
                  5.2. Drug Class Market Share Analysis, 2019 & 2027
                  5.3. Drug Class Dashboard
                  5.4. Global Ophthalmic Drugs Market, by Drug Class, 2015 to 2027
                  5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
                       5.5.1. Antiallergy
                           5.5.1.1. Antiallergy market, 2015 - 2027 (USD Million)
                       5.5.2. Anti-VEGF agents
                           5.5.2.1. Anti-VEGF market, 2015 - 2027 (USD Million)
                       5.5.3. Anti-inflammatory
                           5.5.3.1. Anti-inflammatory market, 2015 - 2027 (USD Million)
                           5.5.3.2. Nonsteroidal drugs
                               5.5.3.2.1. Nonsteroidal market, 2015 - 2027 (USD Million)
                           5.5.3.3. Steroidal drugs
                               5.5.3.3.1. Steroidal market, 2015 - 2027 (USD Million)
                       5.5.4. Antiglaucoma
                           5.5.4.1. Antiglaucoma market, 2015 - 2027 (USD Million)
                       5.5.5. Others
                           5.5.5.1. Others market, 2015 - 2027 (USD Million)
Chapter 6. Ophthalmic Drugs Market: Disease Estimates & Trend Analysis
                  6.1. Definitions & Scope
                  6.2. Disease Market Share Analysis, 2019 & 2027
                  6.3. Disease Dashboard
                  6.4. Global Ophthalmic Drugs Market, by Disease, 2015 to 2027
                  6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
                       6.5.1. Dry Eye
                           6.5.1.1. Dry eye market, 2015 - 2027 (USD Million)
                       6.5.2. Eye Allergy
                           6.5.2.1. Eye allergy market, 2015 - 2027 (USD Million)
                       6.5.3. Glaucoma
                           6.5.3.1. Glaucoma market, 2015 - 2027 (USD Million)
                       6.5.4. Eye Infection
                           6.5.4.1. Eye infection market, 2015 - 2027 (USD Million)
                       6.5.5. Retinal Disorders
                           6.5.5.1. Retinal disorders market, 2015 - 2027 (USD Million)
                           6.5.5.2. Macular Degeneration
                               6.5.5.2.1. Macular degeneration market, 2015 - 2027 (USD Million)
                           6.5.5.3. Diabetic Retinopathy
                               6.5.5.3.1. Diabetic retinopathy market, 2015 - 2027 (USD Million)
                           6.5.5.4. Others
                               6.5.5.4.1. Others market, 2015 - 2027 (USD Million)
                       6.5.6. Uveitis
                           6.5.6.1. Uveitis market, 2015 - 2027 (USD Million)
Chapter 7. Ophthalmic Drugs Market: Dosage Form Estimates & Trend Analysis
                  7.1. Definitions & Scope
                  7.2. Dosage Form Market Share Analysis, 2019 & 2027
                  7.3. Dosage Form Dashboard
                  7.4. Global Ophthalmic Drugs Market, by Dosage Form, 2015 to 2027
                  7.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
                       7.5.1. Gels
                           7.5.1.1. Gels market, 2015 - 2027 (USD Million)
                       7.5.2. Eye solutions
                           7.5.2.1. Eye solutions market, 2015 - 2027 (USD Million)
                       7.5.3. Capsules & Tablets
                           7.5.3.1. Capsules & tablets market, 2015 - 2027 (USD Million)
                       7.5.4. Eye drops
                           7.5.4.1. Eye drops market, 2015 - 2027 (USD Million)
                       7.5.5. Ointments
                           7.5.5.1. Ointments market, 2015 - 2027 (USD Million)
Chapter 8. Ophthalmic Drugs Market: Route of Administration Estimates & Trend Analysis
                  8.1. Definitions & Scope
                  8.2. Route of Administration Market Share Analysis, 2019 & 2027
                  8.3. Route of Administration Dashboard
                  8.4. Global Ophthalmic Drugs Market, by Route of Administration, 2015 to 2027
                  8.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
                       8.5.1. Topical
                           8.5.1.1. Topical market, 2015 - 2027 (USD Million)
                       8.5.2. Local Ocular
                           8.5.2.1. Local Ocular market, 2015 - 2027 (USD Million)
                           8.5.2.2. Subconjunctival
                               8.5.2.2.1. Subconjunctival market, 2015 - 2027 (USD Million)
                           8.5.2.3. Intravitreal
                               8.5.2.3.1. Intravitreal market, 2015 - 2027 (USD Million)
                           8.5.2.4. Retrobulbar
                               8.5.2.4.1. Retrobulbar market, 2015 - 2027 (USD Million)
                           8.5.2.5. Intracameral
                               8.5.2.5.1. Intracameral market, 2015 - 2027 (USD Million)
Chapter 9. Ophthalmic Drugs Market: Product Type Estimates & Trend Analysis
                  9.1. Definitions & Scope
                  9.2. Product Type Market Share Analysis, 2019 & 2027
                  9.3. Product Type Dashboard
                  9.4. Global Ophthalmic Drugs Market, by Product Type, 2015 to 2027
                  9.5. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
                       9.5.1. Prescription drugs
                           9.5.1.1. Prescription drugs market, 2015 - 2027 (USD Million)
                       9.5.2. OTC drugs
                           9.5.2.1. OTC drugs market, 2015 - 2027 (USD Million)
Chapter 10. Ophthalmic Drugs Market: Regional Estimates & Trend analysis, by Disease, Dosage Form, Product Type, Drug Class, And Route of Administration:
                  10.1. Regional Market Snapshot
                  10.2. Regional Market Share and Leading Players, 2019
                       10.2.1. North America
                       10.2.2. Europe
                       10.2.3. Asia Pacific
                       10.2.4. Latin America
                       10.2.5. Middle East & Africa
                  10.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
                       10.3.1. North America
                       10.3.2. Europe
                       10.3.3. Asia Pacific
                       10.3.4. Latin America
                       10.3.5. Middle East & Africa
                  10.4. Market Size, & Forecasts, and Trend Analysis, 2019 to 2027:
                       10.4.1. North America
                           10.4.1.1. North America ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.1.2. U.S.
                               10.4.1.2.1. U.S. ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.1.3. Canada
                               10.4.1.3.1. Canada ophthalmic drugs market, 2015 - 2027 (USD Million)
                       10.4.2. Europe
                           10.4.2.1. Europe ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.2. U.K.
                               10.4.2.2.1. U.K. ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.3. Germany
                               10.4.2.3.1. Germany ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.4. Spain
                               10.4.2.4.1. Spain ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.5. France
                               10.4.2.5.1. France ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.6. Italy
                               10.4.2.6.1. Italy ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.2.7. Russia
                               10.4.2.7.1. Russia ophthalmic drugs market, 2015 - 2027 (USD Million)
                       10.4.3. Asia Pacific
                           10.4.3.1. Asia Pacific ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.2. China
                               10.4.3.2.1. China ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.3. Japan
                               10.4.3.3.1. Japan ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.4. India
                               10.4.3.4.1. India ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.5. South Korea
                               10.4.3.5.1. South Korea ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.6. Singapore
                               10.4.3.6.1. Singapore ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.3.7. Australia
                               10.4.3.7.1. Australia ophthalmic drugs market, 2015 - 2027 (USD Million)
                       10.4.4. Latin America
                           10.4.4.1. Latin America ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.4.2. Brazil
                               10.4.4.2.1. Brazil ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.4.3. Mexico
                               10.4.4.3.1. Mexico ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.4.4. Argentina
                               10.4.4.4.1. Argentina ophthalmic drugs market, 2015 - 2027 (USD Million)
                       10.4.5. Middle East Africa
                           10.4.5.1. MEA ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.5.2. South Africa
                               10.4.5.2.1. South Africa ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.5.3. Saudi Arabia
                               10.4.5.3.1. Saudi Arabia ophthalmic drugs market, 2015 - 2027 (USD Million)
                           10.4.5.4. UAE
                               10.4.5.4.1. UAE ophthalmic drugs market, 2015 - 2027 (USD Million)
Chapter 11. Company Profiles
                  11.1. Alcon
                       11.1.1. Company overview
                       11.1.2. Financial framework
                       11.1.3. Product benchmarking
                       11.1.4. Geographic footprint
                       11.1.5. Strategic initiatives
                  11.2. Novartis AG
                       11.2.1. Company overview
                       11.2.2. Financial framework
                       11.2.3. Product benchmarking
                       11.2.4. Geographic footprint
                       11.2.5. Strategic initiatives
                  11.3. Johnson & Johnson Services Inc.
                       11.3.1. Company overview
                       11.3.2. Financial framework
                       11.3.3. Product benchmarking
                       11.3.4. Geographic footprint
                       11.3.5. Strategic initiatives
                  11.4. Merck Sharp & Dohme Corp.
                       11.4.1. Company overview
                       11.4.2. Financial framework
                       11.4.3. Product benchmarking
                       11.4.4. Geographic footprint
                       11.4.5. Strategic initiatives
                  11.5. Regeneron
                       11.5.1. Company overview
                       11.5.2. Financial framework
                       11.5.3. Product benchmarking
                       11.5.4. Geographic footprint
                       11.5.5. Strategic initiatives
                  11.6. ALLERGAN
                       11.6.1. Company overview
                       11.6.2. Financial framework
                       11.6.3. Product benchmarking
                       11.6.4. Geographic footprint
                       11.6.5. Strategic initiatives
                  11.7. Pfizer, Inc.
                       11.7.1. Company overview
                       11.7.2. Financial framework
                       11.7.3. Product benchmarking
                       11.7.4. Geographic footprint
                       11.7.5. Strategic initiatives
                  11.8. Bausch Health
                       11.8.1. Company overview
                       11.8.2. Financial framework
                       11.8.3. Product benchmarking
                       11.8.4. Geographic footprint
                       11.8.5. Strategic initiatives
                  11.9. Bayer AG
                       11.9.1. Company overview
                       11.9.2. Financial framework
                       11.9.3. Product benchmarking
                       11.9.4. Geographic footprint
                       11.9.5. Strategic initiatives
                  11.10. Santen Pharmaceutical Co., Ltd
                       11.10.1. Company overview
                       11.10.2. Financial framework
                       11.10.3. Product benchmarking
                       11.10.4. Geographic footprint
                       11.10.5. Strategic initiatives
                  11.11. Genentech, Inc.
                       11.11.1. Company overview
                       11.11.2. Financial framework
                       11.11.3. Product benchmarking
                       11.11.4. Geographic footprint
                       11.11.5. Strategic initiatives
List of Tables

TABLE 1 List of Abbreviation
TABLE 2 North America Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 3 North America Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 4 North America Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 5 North America Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 6 North America Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 7 North America Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 8 North America Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 9 North America Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 10 North America Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 11 North America Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 12 North America Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 13 North America Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 14 North America Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 15 North America Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 16 U.S. Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 17 U.S. Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 18 U.S. Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 19 U.S. Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 20 U.S. Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 21 U.S. Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 22 U.S. Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 23 U.S. Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 24 U.S. Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 25 U.S. Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 26 U.S. Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 27 U.S. Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 28 U.S. Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 29 U.S. Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 30 Canada Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 31 Canada Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 32 Canada Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 33 Canada Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 34 Canada Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 35 Canada Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 36 Canada Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 37 Canada Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 38 Canada Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 39 Canada Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 40 Canada Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 41 Canada Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 42 Canada Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 43 Canada Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 44 Europe Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 45 Europe Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 46 Europe Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 47 Europe Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 48 Europe Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 49 Europe Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 50 Europe Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 51 Europe Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 52 Europe Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 53 Europe Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 54 Europe Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 55 Europe Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 56 Europe Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 57 Europe Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 58 U.K. Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 59 U.K. Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 60 U.K. Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 61 U.K. Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 62 U.K. Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 63 U.K. Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 64 U.K. Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 65 U.K. Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 66 U.K. Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 67 U.K. Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 68 U.K. Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 69 U.K. Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 70 U.K. Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 71 U.K. Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 72 Germany Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 73 Germany Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 74 Germany Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 75 Germany Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 76 Germany Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 77 Germany Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 78 Germany Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 79 Germany Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 80 Germany Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 81 Germany Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 82 Germany Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 83 Germany Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 84 Germany Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 85 Germany Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 86 France Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 87 France Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 88 France Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 89 France Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 90 France Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 91 France Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 92 France Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 93 France Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 94 France Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 95 France Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 96 France Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 97 France Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 98 France Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 99 France Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 100 Italy Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 101 Italy Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 102 Italy Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 103 Italy Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 104 Italy Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 105 Italy Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 106 Italy Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 107 Italy Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 108 Italy Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 109 Italy Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 110 Italy Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 111 Italy Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 112 Italy Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 113 Italy Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 114 Spain Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 115 Spain Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 116 Spain Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 117 Spain Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 118 Spain Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 119 Spain Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 120 Spain Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 121 Spain Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 122 Spain Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 123 Spain Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 124 Spain Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 125 Spain Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 126 Spain Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 127 Spain Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 128 Russia Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 129 Russia Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 130 Russia Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 131 Russia Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 132 Russia Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 133 Russia Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 134 Russia Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 135 Russia Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 136 Russia Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 137 Russia Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 138 Russia Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 139 Russia Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 140 Russia Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 141 Russia Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 142 Asia Pacific Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 143 Asia Pacific Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 144 Asia Pacific Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 145 Asia Pacific Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 146 Asia Pacific Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 147 Asia Pacific Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 148 Asia Pacific Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 149 Asia Pacific Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 150 Asia Pacific Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 151 Asia Pacific Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 152 Asia Pacific Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 153 Asia Pacific Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 154 Asia Pacific Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 155 Asia Pacific Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 156 Japan Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 157 Japan Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 158 Japan Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 159 Japan Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 160 Japan Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 161 Japan Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 162 Japan Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 163 Japan Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 164 Japan Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 165 Japan Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 166 Japan Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 167 Japan Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 168 Japan Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 169 Japan Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 170 China Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 171 China Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 172 China Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 173 China Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 174 China Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 175 China Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 176 China Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 177 China Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 178 China Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 179 China Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 180 China Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 181 China Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 182 China Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 183 China Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 184 India Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 185 India Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 186 India Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 187 India Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 188 India Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 189 India Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 190 India Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 191 India Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 192 India Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 193 India Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 194 India Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 195 India Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 196 India Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 197 India Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 198 South Korea Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 199 South Korea Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 200 South Korea Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 201 South Korea Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 202 South Korea Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 203 South Korea Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 204 South Korea Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 205 South Korea Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 206 South Korea Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 207 South Korea Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 208 South Korea Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 209 South Korea Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 210 South Korea Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 211 South Korea Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 212 Australia Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 213 Australia Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 214 Australia Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 215 Australia Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 216 Australia Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 217 Australia Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 218 Australia Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 219 Australia Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 220 Australia Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 221 Australia Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 222 Australia Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 223 Australia Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 224 Australia Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 225 Australia Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 226 Singapore Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 227 Singapore Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 228 Singapore Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 229 Singapore Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 230 Singapore Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 231 Singapore Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 232 Singapore Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 233 Singapore Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 234 Singapore Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 235 Singapore Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 236 Singapore Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 237 Singapore Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 238 Singapore Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 239 Singapore Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 240 Latin America Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 241 Latin America Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 242 Latin America Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 243 Latin America Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 244 Latin America Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 245 Latin America Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 246 Latin America Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 247 Latin America Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 248 Latin America Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 249 Latin America Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 250 Latin America Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 251 Latin America Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 252 Latin America Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 253 Latin America Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 254 Brazil Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 255 Brazil Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 256 Brazil Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 257 Brazil Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 258 Brazil Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 259 Brazil Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 260 Brazil Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 261 Brazil Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 262 Brazil Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 263 Brazil Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 264 Brazil Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 265 Brazil Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 266 Brazil Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 267 Brazil Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 268 Mexico Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 269 Mexico Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 270 Mexico Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 271 Mexico Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 272 Mexico Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 273 Mexico Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 274 Mexico Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 275 Mexico Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 276 Mexico Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 277 Mexico Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 278 Mexico Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 279 Mexico Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 280 Mexico Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 281 Mexico Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 282 Argentina Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 283 Argentina Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 284 Argentina Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 285 Argentina Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 286 Argentina Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 287 Argentina Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 288 Argentina Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 289 Argentina Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 290 Argentina Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 291 Argentina Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 292 Argentina Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 293 Argentina Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 294 Argentina Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 295 Argentina Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 296 MEA Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 297 MEA Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 298 MEA Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 299 MEA Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 300 MEA Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 301 MEA Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 302 MEA Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 303 MEA Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 304 MEA Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 305 MEA Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 306 MEA Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 307 MEA Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 308 MEA Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 309 MEA Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 310 South Africa Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 311 South Africa Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 312 South Africa Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 313 South Africa Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 314 South Africa Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 315 South Africa Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 316 South Africa Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 317 South Africa Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 318 South Africa Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 319 South Africa Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 320 South Africa Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 321 South Africa Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 322 South Africa Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 323 South Africa Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 324 Saudi Arabia Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 325 Saudi Arabia Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 326 Saudi Arabia Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 327 Saudi Arabia Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 328 Saudi Arabia Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 329 Saudi Arabia Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 330 Saudi Arabia Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 331 Saudi Arabia Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 332 Saudi Arabia Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 333 Saudi Arabia Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 334 Saudi Arabia Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 335 Saudi Arabia Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 336 Saudi Arabia Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 337 Saudi Arabia Local Ocular Market, by Type, 2015 - 2027 (USD Million)
TABLE 338 UAE Ophthalmic Drugs Market, by Drug Class, 2015 - 2027 (USD Million)
TABLE 339 UAE Anti-inflammatory Market, by Type, 2015 - 2027 (USD Million)
TABLE 340 UAE Ophthalmic Drugs Market, by Disease, 2015 - 2027 (USD Million)
TABLE 341 UAE Dry Eye Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 342 UAE Eye Allergy Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 343 UAE Glaucoma Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 344 UAE Infection Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 345 UAE Retinal Disorders Market, by Type, 2015 - 2027 (USD Million)
TABLE 346 UAE Retinal Disorders Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 347 UAE Uveitis Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 348 UAE Ophthalmic Drugs Market, by Dosage Form, 2015 - 2027 (USD Million)
TABLE 349 UAE Ophthalmic Drugs Market, by Route of Administration, 2015 - 2027 (USD Million)
TABLE 350 UAE Ophthalmic Drugs Market, by Product Type, 2015 - 2027 (USD Million)
TABLE 351 UAE Local Ocular Market, by Type, 2015 - 2027 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global ophthalmic drugs- Key market driver analysis
FIG. 7 Global ophthalmic drugs market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Factors estimated to impact on market growth
FIG. 10 Global ophthalmic drugs market - Porter’s analysis
FIG. 11 Global ophthalmic drugs market - PESTEL analysis
FIG. 12 Global ophthalmic drugs market drug class outlook key takeaways
FIG. 13 Global ophthalmic drugs market: Drug Class movement analysis
FIG. 14 Antiallergy market estimates, 2015 - 2027 (USD Million)
FIG. 15 Anti-VEGF agents market estimates, 2015 - 2027 (USD Million)
FIG. 16 Anti-inflammatory market estimates, 2015 - 2027 (USD Million)
FIG 17 Non-steroidal drugs market estimates, 2015 - 2027 (USD Million)
FIG. 18 Steroidal market estimates, 2015 - 2027 (USD Million)
FIG. 19 Antiglaucoma market estimates, 2015 - 2027 (USD Million)
FIG. 20 Others market estimates, 2015 - 2027 (USD Million)
FIG. 21 Global ophthalmic drugs market disease outlook key takeaways
FIG. 22 Global ophthalmic drugs market: Disease movement analysis
FIG. 23 Dry eye market estimates, 2015 - 2027 (USD Million)
FIG. 24 Eye Allergy market estimates, 2015 - 2027 (USD Million)
FIG. 25 Glaucoma market estimates, 2015 - 2027 (USD Million)
FIG. 26 Eye Infection market estimates, 2015 - 2027 (USD Million)
FIG. 27 Retinal disorders market estimates, 2015 - 2027 (USD Million)
FIG. 28 Macular degeneration market estimates, 2015 - 2027 (USD Million)
FIG. 29 Diabetic retinopathy market estimates, 2015 - 2027 (USD Million)
FIG. 30 Others market estimates, 2015 - 2027 (USD Million)
FIG. 31 Uveitis market estimates, 2015 - 2027 (USD Million)
FIG. 32 Others market estimates, 2015 - 2027 (USD Million)
FIG. 33 Global ophthalmic drugs market dosage form outlook key takeaways
FIG. 34 Global ophthalmic drugs market: Dosage Form movement analysis
FIG. 35 Gels market estimates, 2015 - 2027 (USD Million)
FIG. 36 Eye solutions market estimates, 2015 - 2027 (USD Million)
FIG. 37 Capsules & tablets market estimates, 2015 - 2027 (USD Million)
FIG. 38 Eye drops market estimates, 2015 - 2027 (USD Million)
FIG. 39 Ointments market estimates, 2015 - 2027 (USD Million)
FIG. 40 Global ophthalmic drugs market route of administration outlook key takeaways
FIG. 41 Global ophthalmic drugs market: Route of administration movement analysis
FIG. 42 Topical market estimates, 2015 - 2027 (USD Million)
FIG. 43 Local ocular market estimates, 2015 - 2027 (USD Million)
FIG. 44 Subconjunctival market estimates, 2015 - 2027 (USD Million)
FIG. 45 Intravitreal market estimates, 2015 - 2027 (USD Million)
FIG. 46 Retrobulbar market estimates, 2015 - 2027 (USD Million)
FIG. 47 Intracameral market estimates, 2015 - 2027 (USD Million)
FIG. 48 Systemic market estimates, 2015 - 2027 (USD Million)
FIG. 49 Global ophthalmic drugs market product type outlook key takeaways
FIG. 50 Global ophthalmic drugs market: Product type movement analysis
FIG. 51 Prescription drugs market estimates, 2015 - 2027 (USD Million)
FIG. 52 OTC drugs market estimates, 2015 - 2027 (USD Million)
FIG. 53 Regional market place: Key takeaways
FIG. 54 Global ophthalmic drugs market: Regional movement analysis
FIG. 55 North America ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 56 U.S. ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 57 Canada ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 58 Europe ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 59 U.K. ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 60 Germany ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 61 France ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 62 Spain ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 63 Italy ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 64 Russia ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 65 Asia Pacific ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 66 Japan ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 67 China ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 68 India ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 69 South Korea ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 70 Singapore ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 71 Australia ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 72 Latin America ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 73 Brazil ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 74 Mexico ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 75 Argentina ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 76 MEA ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 77 South Africa ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 78 UAE market, 2015 - 2027 (USD Million)
FIG. 79 Saudi Arabia ophthalmic drugs market, 2015 - 2027 (USD Million)
FIG. 80 Strategy framework 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $5950
Multi User - US $6950
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify